A Young Girl’s Sudden Bilateral Mydriasis and Abnormal Gait
A 3-year-old girl with an unremarkable medical history suddenly developed…
Browsing Tag
Mydriasis
Ocuphire Pharma Enters into a Global License Agreement for Development and…
Ocuphire to Receive $35 Million Upfront, Nyxol Development Funding and Additional Potential Milestone Payments plus Tiered Double-Digit Royalties Strengthened Financial Position Supports…
Ocuphire Announces Enrollment of First Patients in Second Phase 3 Pivotal Trial…
RM Indication Allows for Rapid Recruitment with Top-line Results Expected in Early 2022 Nyxol has the Potential Opportunity to Address Estimated $500M+ Reversal of Dilation Market with…